Skip to main content
KLRA filings

Corporate insider profile

Andrew T. Kaplan Filing Activity

Latest reported as Director / 10% Owner of Kailera Therapeutics, Inc. (KLRA).

Purchase filings
1
Reported companies
1
Net open-market value
$134,375,008
Latest transaction
Apr 20, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 20, 2026Kailera Therapeutics, Inc. (KLRA)Director / 10% OwnerOpen Market Purchase8,398,438$16.00$134,375,008